Chan HL - Search Results

1

Treatment of chronic hepatitis B: focus on telbivudine.

Lui YY, Chan HL. Lui YY, et al. Among authors: chan hl. Expert Rev Anti Infect Ther. 2009 Apr;7(3):259-68. doi: 10.1586/eri.09.6. Expert Rev Anti Infect Ther. 2009. PMID: 19344240 Review.

2

Icteric flare of chronic hepatitis B in a 95-year old patient.

Song W, Leung WK, Chan HL. Song W, et al. Among authors: chan hl. World J Gastroenterol. 2003 Dec;9(12):2876-7. doi: 10.3748/wjg.v9.i12.2876. World J Gastroenterol. 2003. PMID: 14669358 Free PMC article.

3

Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy.

Sung JJ, Wong ML, Bowden S, Liew CT, Hui AY, Wong VW, Leung NW, Locarnini S, Chan HL. Sung JJ, et al. Among authors: chan hl. Gastroenterology. 2005 Jun;128(7):1890-7. doi: 10.1053/j.gastro.2005.03.009. Gastroenterology. 2005. PMID: 15940624 Clinical Trial.

4

Quantitative subtyping of hepatitis B virus reveals complex dynamics of YMDD motif mutants development during long-term lamivudine therapy.

Ding C, Wong VW, Chow KC, Chan HY, Hui AY, Wong GL, Lo YM, Sung JJ, Chan HL. Ding C, et al. Among authors: chan hy, chan hl. Antivir Ther. 2006;11(8):1041-9. Antivir Ther. 2006. PMID: 17302374

5

Randomized trial of interferon beta-1a with or without ribavirin in Asian patients with chronic hepatitis C.

Chan HL, Ren H, Chow WC, Wee T; Interferon beta-1a Hepatitis C Study Group. Chan HL, et al. Hepatology. 2007 Aug;46(2):315-23. doi: 10.1002/hep.21683. Hepatology. 2007. PMID: 17654600 Clinical Trial.

6

Treatment of hepatitis B e antigen positive chronic hepatitis with telbivudine or adefovir: a randomized trial.

Chan HL, Heathcote EJ, Marcellin P, Lai CL, Cho M, Moon YM, Chao YC, Myers RP, Minuk GY, Jeffers L, Sievert W, Bzowej N, Harb G, Kaiser R, Qiao XJ, Brown NA; 018 Study Group. Chan HL, et al. Ann Intern Med. 2007 Dec 4;147(11):745-54. doi: 10.7326/0003-4819-147-11-200712040-00183. Epub 2007 Oct 1. Ann Intern Med. 2007. PMID: 17909201 Free article. Clinical Trial.

7

Treatment of patients with chronic hepatitis B who have failed previous antiviral treatment with pegylated interferon alpha2a (40 kda; PEGASYS).

Chan HL, Wong VW, Chim AM, Wong GL, Chan HY, Sung JJ. Chan HL, et al. Among authors: chan hy. Antivir Ther. 2008;13(4):555-62. Antivir Ther. 2008. PMID: 18672534 Clinical Trial.

8

A review of telbivudine for the management of chronic hepatitis B virus infection.

Lui YY, Chan HL. Lui YY, et al. Among authors: chan hl. Expert Opin Drug Metab Toxicol. 2008 Oct;4(10):1351-61. doi: 10.1517/17425255.4.10.1351. Expert Opin Drug Metab Toxicol. 2008. PMID: 18798704 Review.

9

Lamivudine monoprophylaxis and adefovir salvage for liver transplantation in chronic hepatitis B: a seven-year follow-up study.

Limquiaco JL, Wong J, Wong VW, Wong GL, Tse CH, Chan HY, Kwan KY, Lai PB, Chan HL. Limquiaco JL, et al. Among authors: chan hy, chan hl. J Med Virol. 2009 Feb;81(2):224-9. doi: 10.1002/jmv.21369. J Med Virol. 2009. PMID: 19107976

10

Predictors of treatment response in chronic hepatitis B.

Wong GL, Chan HL. Wong GL, et al. Among authors: chan hl. Drugs. 2009 Nov 12;69(16):2167-77. doi: 10.2165/11319850-000000000-00000. Drugs. 2009. PMID: 19852523 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,249 results

Search Page

Filters